Y-Intercept (HK)’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
CPC
AIM
AAMU
AAIS
BCAM
Y-Intercept (HK)'s DGX Position: Q2 2026 in Review
Y-Intercept (HK) sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 13,146 shares — an estimated $2.58M sold.
Y-Intercept (HK) first reported a position in DGX in Q1 2021 and held it in 10 quarters. The position peaked at $5.19M in Q4 2025. 289 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Y-Intercept (HK) reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
- Y-Intercept (HK) sold 13,146 Quest Diagnostics shares in Q2 2026, an estimated $2.58M.
- Y-Intercept (HK) first reported a position in Quest Diagnostics in Q1 2021 and held it in 10 quarters.
- Y-Intercept (HK)'s Quest Diagnostics position peaked at $5.19M in Q4 2025.
- 289 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.